BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 12, 2008
View Archived Issues
Sanofi-aventis reports Q2 highlights
Read More
Santhera provides update on idebenone for the treatment of Friedreich's ataxia
Read More
KUR-212 follow-up results of phase IIa trial in patients with burns requiring mesh grafting
Read More
Enrollment in phase IIb clinical trial for I-vation TA (MK-0140) suspended
Read More
New delta opioid receptor antagonist with antitussive activity identified at Toray
Read More
Bioavailability similar with ritonavir tablet and capsule formulations
Read More
Study shows long-term efficacy of tipranavir-ritonavir treatment for children with AIDS
Read More
CASTLE data on atenovir/ritonavir, lopinavir/ritonavir analyzed by gender, race and renal effects
Read More
AstraZeneca: Q2 regulatory and development update
Read More
Aloe extract UP-780 upregulates adiponectin expression, reduces HbA1c
Read More
Novel antiviral, antibacterial agents disclosed in recent patents
Read More
New compounds for treatment of inflammation revealed in patent literature
Read More
Recent patents disclose new anticancer compounds
Read More
NeuroSearch reports positive results from TIPO-2 human metabolic study of tesofensine
Read More
FDA grants marketing approval to Gilead's Viread for chronic hepatitis B
Read More
FDA issues approvable letter for NDA for Kynapid in atrial fibrillation
Read More
Oncolytics completes dose escalation in REO 010 clinical trial of Reolysin and docetaxel
Read More
Enrollment completed in phase IIa study of brostallicin in soft tissue carcinoma
Read More
Fresenius Kabi completes acquisition of Dabur Pharma
Read More
Preclinical data on memogain, a galantamine prodrug, reported by Galantos
Read More
ErbB3 antagonist MM-121 begins phase I trial
Read More
Phase III study of Trizytek meets primary endpoint
Read More
